	Impact of In-Office Dispensing Adoption by Urology Practices on Oral Specialty Drug Use in Advanced Prostate Cancer. Cancer Med Faraj KS, Oerline M, Kaufman SR, Dall C, Srivastava A, Liu X, Caram MEV, Shahinian VB, Hollenbeck BK. PMID: 41521275 [PubMed - indexed for MEDLINE]
	Theranostic Nanoparticles in Prostate Cancer: Disrupting Hypoxia-Induced Glycolysis by Targeting Hypoxia-Inducible Factor-1 Alpha and Downstream Metabolites. Cancer Med Uti DE, Omang WA, Alum EU, Bawa I, Ugwu OP, Idowu AO, Atangwho IJ, Egbung GE. PMID: 41521160 [PubMed - indexed for MEDLINE]
	The Performance of MR Cytometry Imaging in Differentiating High- and Low-Grade Bladder Cancer. J Magn Reson Imaging Chen L, Jin C, Guo E, Liu F, Wang Y, Zhu J, Zhang X, Zhang J, Xu Z, Bai X, Wu Y, Tan Z, Jiang X, Feiweier T, Jin Z, Xu J, Guo H, Zhang G, Xue H, Shi D, Sun H. PMID: 41521156 [PubMed - as supplied by publisher]
	Living with a Prostate Cancer Patient: Real-world Evidence from the Europa Uomo Prostate Cancer Partners in Europe Research Study. Eur Urol Oncol Venderbos LDF, Remmers S, Deschamps A, Boogh I, Estape T, Carl EG, Azevedo NP, Roobol MJ. PMID: 41521096 [PubMed - as supplied by publisher]
	Comparison of the Oncologic Outcomes of Cryoablation, Laser Ablation, and Hyperthermia for Localized Prostate Cancer: A Population-Based Cohort Study Using the SEER Database. Clin Genitourin Cancer Guo RQ, Sun J, Bie ZX, Li YM. PMID: 41521094 [PubMed - as supplied by publisher]
	The Role of Nutrition in Prostate Cancer Risk, Progression, and Mortality: A Comprehensive Review. Clin Nutr ESPEN Souroujon AA, Sundaresan V, Golos A, Leapman M, Gomez-Santamaría OA, Casilla-Lennon M. PMID: 41520878 [PubMed - as supplied by publisher]
	Molecular characterization of palmitoylation in prostate cancer reveals KIFC2 as a prognostic biomarker and potential therapeutic target. Comput Biol Med Huang L, Jiang S, Zeng F, Zeng G, Shan H. PMID: 41520472 [PubMed - as supplied by publisher]
	Comparative efficacy of hyperthermic chemotherapy and BCG instillation in non-muscle invasive bladder cancer: a systematic review and meta-analysis. Int Urol Nephrol Chai Y, Zhou Y, Peng H, Jiang Y, Dai J, Liu J. PMID: 41520313 [PubMed - as supplied by publisher]
	Feasibility and first-year findings of a pilot program of prostate cancer screening in Croatia (CROState). Croat Med J Ka, Kuli, Grubi, Brki, Prutki M, Buba, Capak K. PMID: 41520199 [PubMed - indexed for MEDLINE]
	Pre-diagnostic circulating untargeted metabolomics and risk of overall and clinically significant prostate cancer: a systematic review andÂ meta-analysis. Br J Cancer Fuller H, Agasaro OP, Guevara JM, Darst BF. PMID: 41520058 [PubMed - as supplied by publisher]
	Subsequent-line Systemic Therapy for Metastatic or Recurrent Penile Cancer: A Systematic Review of Efficacy, Toxicity, and Outcomes. Eur Urol Focus Garaz R, Ziada M, Crozier J, Pang KH, Alnajjar HM, Alifrangis C, Tsaur I, Muneer A. PMID: 41519649 [PubMed - as supplied by publisher]
	Cross-omics interpretable neural network for discovery of molecular markers in prostate cancer. Comput Biol Chem Chen X, Yi S, Yuemaierabola A, Liu Y, He L, Ma J, Guo W, Sun G. PMID: 41518989 [PubMed - as supplied by publisher]
	Hereditary renal cell carcinoma surveillance protocols: a review of the literature and proposed recommendations. Fam Cancer Miranda M, Ferreira C, Fernandes M, Lopes F, Ye A, Sousa AB, Costa L, Palma Dos Reis J, Palmela Leitão T. PMID: 41518461 [PubMed - indexed for MEDLINE]
	Lesion distribution and prognosis of renal cell carcinoma bone metastasis: A novel evaluation model based on random survival forests. Int J Cancer Huang Z, Yu L, Zhang X, Li Q, Liu S, Xu T. PMID: 41518076 [PubMed - as supplied by publisher]
	An update on the treatment paradigm for non-clear cell renal cell carcinoma. Expert Rev Clin Pharmacol Rametta A, Crippa N, Rota S, Gusmaroli E, Stellato M, Verzoni E, Nuzzo A, Claps M, Guadalupi V, Procopio G. PMID: 41517842 [PubMed - as supplied by publisher]
	Optimizing Ki-67 and E-Cadherin Thresholds for Improved Grade and Stage Classification in Urothelial Bladder Cancer. J Clin Med Harsanyi S, Novakova ZV, Neuschlova L, Galbavy S, Danisovic L, Ziaran S, Bevizova K. PMID: 41517587 [PubMed]
	Identification of a Muscle-Invasive Bladder Carcinoma Molecular Subtype of Poor Responders to Neoadjuvant Chemotherapy and High Expression of Targetable Biomarkers. Int J Mol Sci Trilla-Fuertes L, Pedregosa-Barbas J, García-Fernández E, Zambrana F, Martínez-Salas I, Gajate P, Becerril-Gómez F, Lalanda-Delgado P, Dittmann A, López-Vacas R, Kunz L, Rubio G, Nieto-Torrero S, Pertejo A, González-Peramato P, Fresno Vara JÁ, Gámez-Pozo A, Pinto-Marín Á. PMID: 41516353 [PubMed - indexed for MEDLINE]
	Conceptualization of an Ex Vivo Organ Culture (EVOC) Model for Human Seminoma: A Pilot Study. Int J Mol Sci Demyashkin G, Shchekin V, Parshenkov M, Shegay P, Kaprin A. PMID: 41516325 [PubMed - indexed for MEDLINE]
	Novel Mixed Cancer-Cell Models Designed to Capture Inter-Patient Tumor Heterogeneity for Accurate Evaluation of Drug Combinations. Int J Mol Sci Jena S, Kim DC, Lee AM, Zhang W, Zhan K, Elmorsi RM, Li Y, Dehm SM, Huang RS. PMID: 41516287 [PubMed - indexed for MEDLINE]
	The Diagnostic Performance of a Four-Gene Digital Droplet PCR Panel for Urine Liquid Biopsy in Urothelial Bladder Cancer. Diagnostics (Basel) Jain M, Tivtikyan A, Kislyakov D, Rakhmatullin T, Kamalov D, Kokarev V, Vorobeva L, Samokhodskaya L, Zvereva M, Kamalov A. PMID: 41515564 [PubMed]

Articles 1 - 20 / 175147

Page 1 of 8758



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy